Neuberger Berman Group LLC Neurocrine Biosciences Inc Transaction History

Neuberger Berman Group LLC

$123 Billion
Q3 2024

A detailed history of Neuberger Berman Group LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Neuberger Berman Group LLC holds 159,543 shares of NBIX stock, worth $21.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

159,543

Previous 123,741 28.93%

Holding current value

$21.6 Million

Previous $17 Million 7.83%

% of portfolio

0.01%

Previous 0.01%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$114.58 - $153.15 $4.1 Million - $5.48 Million	35,802 Added 28.93%	159,543 $18.4 Million
Q2 2024 Nov 14, 2024	BUY	$130.86 - $143.19 $877,939 - $960,661	6,709 Added 5.73%	123,741 $17 Million
Q2 2024 Aug 13, 2024	BUY	$130.86 - $143.19 $877,939 - $960,661	6,709 Added 5.73%	123,741 $17 Million
Q1 2024 Nov 14, 2024	BUY	$130.4 - $143.74 $427,060 - $470,748	3,275 Added 2.88%	117,032 $16.1 Million
Q1 2024 May 13, 2024	BUY	$130.4 - $143.74 $15.3 Million - $16.8 Million	117,032 New	117,032 $16.1 Million
Q4 2023 Nov 14, 2024	SELL	$106.07 - $132.76 $1.06 Million - $1.33 Million	-9,984 Reduced 8.07%	113,757 $15 Million
Q4 2023 Feb 09, 2024	BUY	$106.07 - $132.76 $319,482 - $399,873	3,012 Added 2.72%	113,757 $15 Million
Q3 2023 Nov 14, 2023	BUY	$94.02 - $117.1 $33,377 - $41,570	355 Added 0.32%	110,745 $12.5 Million
Q2 2023 Aug 11, 2023	BUY	$89.53 - $104.87 $9.31 Million - $10.9 Million	103,961 Added 1617.06%	110,390 $10.4 Million
Q1 2023 May 12, 2023	SELL	$94.11 - $123.02 $3,105 - $4,059	-33 Reduced 0.51%	6,429 $650,000
Q4 2022 Feb 13, 2023	SELL	$106.72 - $127.06 $9,177 - $10,927	-86 Reduced 1.31%	6,462 $771,000
Q3 2022 Nov 15, 2022	SELL	$92.03 - $107.81 $105,006 - $123,011	-1,141 Reduced 14.84%	6,548 $696,000
Q2 2022 Aug 15, 2022	BUY	$75.79 - $100.07 $15,688 - $20,714	207 Added 2.77%	7,689 $750,000
Q1 2022 May 13, 2022	BUY	$72.45 - $94.81 $213,582 - $279,499	2,948 Added 65.02%	7,482 $699,000
Q4 2021 Feb 11, 2022	BUY	$79.65 - $106.22 $108,722 - $144,990	1,365 Added 43.07%	4,534 $379,000
Q3 2021 Nov 12, 2021	BUY	$86.18 - $99.03 $2,413 - $2,772	28 Added 0.89%	3,169 $301,000
Q2 2021 Aug 13, 2021	BUY	$89.43 - $102.27 $17,081 - $19,533	191 Added 6.47%	3,141 $305,000
Q1 2021 May 13, 2021	SELL	$87.57 - $119.4 $28,898 - $39,402	-330 Reduced 10.06%	2,950 $287,000
Q4 2020 Feb 10, 2021	BUY	$86.91 - $108.33 $1,651 - $2,058	19 Added 0.58%	3,280 $315,000
Q3 2020 Nov 12, 2020	BUY	$96.16 - $135.15 $31,732 - $44,599	330 Added 11.26%	3,261 $313,000
Q2 2020 Aug 13, 2020	SELL	$85.09 - $130.36 $4.41 Million - $6.76 Million	-51,832 Reduced 94.65%	2,931 $358,000
Q1 2020 May 14, 2020	SELL	$75.11 - $113.76 $437,665 - $662,879	-5,827 Reduced 9.62%	54,763 $4.74 Million
Q4 2019 Feb 12, 2020	SELL	$86.8 - $118.57 $185,318 - $253,146	-2,135 Reduced 3.4%	60,590 $6.51 Million
Q3 2019 Nov 13, 2019	BUY	$83.82 - $101.5 $5.26 Million - $6.37 Million	62,725 New	62,725 $5.65 Million
Q2 2019 Aug 13, 2019	SELL	$72.24 - $91.27 $5.8 Million - $7.33 Million	-80,284 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$69.31 - $91.53 $5.38 Million - $7.11 Million	-77,663 Reduced 49.17%	80,284 $7.07 Million
Q4 2018 Feb 12, 2019	SELL	$68.32 - $124.36 $8.65 Million - $15.7 Million	-126,635 Reduced 44.5%	157,947 $11.3 Million
Q3 2018 Nov 13, 2018	SELL	$98.88 - $125.85 $4.64 Million - $5.9 Million	-46,913 Reduced 14.15%	284,582 $35 Million
Q2 2018 Aug 13, 2018	SELL	$75.3 - $105.99 $2.21 Million - $3.11 Million	-29,300 Reduced 8.12%	331,495 $32.6 Million
Q1 2018 May 08, 2018	SELL	$75.88 - $92.43 $8.8 Million - $10.7 Million	-116,000 Reduced 24.33%	360,795 $29.9 Million
Q4 2017 Feb 14, 2018	BUY	$58.53 - $77.59 $1.26 Million - $1.67 Million	21,500 Added 4.72%	476,795 $37 Million
Q3 2017 Nov 15, 2017	BUY	$47.97 - $61.28 $21.8 Million - $27.9 Million	455,295	455,295 $27.9 Million

Others Institutions Holding NBIX

# of Institutions

626

Shares Held

94M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Account

Neuberger Berman Group LLC Neurocrine Biosciences Inc Transaction History